Anaphylaxis caused by intravenous fluorescein: Clinical characteristics and review of literature

Internal and Emergency Medicine

Volumn 9, Issue 3, 2014, Pages 325-330

  Ha, Sang Ook ^a   Kim, Dae Yong ^b   Sohn, Chang Hwan ^a   Lim, Kyoung Soo ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Eulji University School of Medicine   (South Korea)

Author keywords

Anaphylaxis; Characteristics; Fluorescein; Hypotension

Indexed keywords

FLUORESCEIN;

AGED; ANAPHYLAXIS; CASE REPORT; CHEMICALLY INDUCED; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDY;

AGED; ANAPHYLAXIS; FEMALE; FLUORESCEIN; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84897021763     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-013-1019-6     Document Type: Article

References (25)

1. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, Brown SG, Camargo CA Jr, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AD Jr, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP, Decker WW (2006) Second symposium on the definition and management of anaphylaxis: summary report-second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med 47: 373-380.
2. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, Brown SGA, Camargo CA Jr, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AD Jr, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FER, Thomas S, Wood JP, Decker WW (2006) Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117: 391-397.
3. Wang J, Sampson HA (2007) Food anaphylaxis. Clin Exp Allergy 37: 651-660.
4. Barnard JH (1973) Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol 52: 259-264.
5. Greenberger PA, Rotskoff BD, Lifschultz B (2007) Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 98: 252-257.
6. Kim SH, Lee SH, Lee SM, Kang HR, Park HW, Kim SS, Cho SH, Min KU, Kim YY, Chang YS (2011) Outcomes of premedication for non-ionic radio-contrast media hypersensitivity reactions in Korea. Eur J Radiol 80: 363-367.
7. Brockow K (2009) Immediate and delayed reactions to radiocontrast media: is there an allergic mechanism? Immunol Allergy Clin N Am 29: 453-468.
8. Wang CL, Cohan RH, Ellis JH, Caoili EM, Wang G, Francis IR (2008) Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol 191: 409-415.
9. Lira RP, Oliveira CL, Marques MV, Silva AR, Pessoa Cde C (2007) Adverse reactions of fluorescein angiography: a prospective study. Arq Bras Oftalmol 70: 615-618.
10. Scranton SE, Gonzalez EG, Waibel KH (2009) Incidence and characteristics of biphasic reactions after allergen immunotherapy. J Allergy Clin Immunol 123: 493-498.
11. Marmor MF, Ravin JG (2011) Fluorescein angiography: insight and serendipity a half century ago. Arch Ophthalmol 129: 943-948.
12. Yannuzzi LA, Rohrer KT, Tindel LJ, Sobel RS, Costanza MA, Shields W, Zang E (1986) Fluorescein angiography complication survey. Ophthalmology 93: 611-617.
13. Kwiterovich KA, Maguire MG, Murphy RP, Schachat AP, Bressler NM, Bressler SB, Fine SL (1991) Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study. Ophthalmology 98: 1139-1142.
14. Breidablik A, De Pater GH, Walther C, Nopp A, Guttormsen AB (2012) Intravenous fluorescein as a cause of immunoglobulin E-mediated anaphylactic shock. Acta Anaesthesiol Scand 56: 1066-1068.
15. Brown AF, McKinnon D, Chu K (2001) Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 108: 861-866.
16. Kemp SF, Lockey RF, Wolf BL, Lieberman P (1995) Anaphylaxis. A review of 266 cases. Arch Intern Med 155: 1749-1754.
17. Smit DV, Cameron PA, Rainer TH (2005) Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. J Emerg Med 28: 381-388.
18. Greene GS, Bell LW, Hitching RA, Spaeth GL (1976) Adverse reaction to intravenous fluorescein: evidence for sex difference. Ann Ophthalmol 8: 533-536.
19. Butner RW, McPherson AR (1983) Adverse reactions in intravenous fluorescein angiography. Ann Ophthalmol 15: 1084-1086.
20. Zografos L (1983) International survey on the incidence of severe or fatal complications which may occur during fluorescein angiography. J Fr Ophtalmol 6: 495-506.
21. Pacurariu RI (1982) Low incidence of side effects following intravenous fluorescein angiography. Ann Ophthalmol 14: 32-36.
22. Kwan AS, Barry C, McAllister IL, Constable I (2006) Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience. Clin Exp Ophthalmol 34: 33-38.
23. Bearelly S, Rao S, Fekrat S (2009) Anaphylaxis following intravenous fluorescein angiography in a vitreoretinal clinic: report of 4 cases. Can J Ophthalmol: Journal canadien d'ophtalmologie 44: 444-445.
24. Balbino M, Silva G, Correia GC (2012) Anaphylaxis with convulsions following intravenous fluorescein angiography at an outpatient clinic. Einstein 10: 374-376.
25. Tole JW, Lieberman P (2007) Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations. Immunol Allergy Clin N Am 27: 309-326 (viii).